The HDHD5 Knockout CAL-27 Polyclonal Cells product consists of a polyclonal population of CAL-27 cells with CRISPR/Cas9-mediated disruption of the HDHD5 gene (Homo sapiens). This edited cell pool contains a heterogeneous array of loss-of-function alleles, providing robust gene inactivation without the need for single-cell cloning. The polyclonal format preserves population diversity and is well-suited for functional studies where clonal variation may confound results.
The parental CAL-27 cell line originates from a human tongue squamous cell carcinoma and represents a standard model for oral cancer research. It retains aggressive growth properties and key molecular features of OSCC, making it a relevant system for investigating tumor biology, drug responses, and metabolic reprogramming. Introducing an HDHD5 knockout in this background permits direct assessment of the gene??s role in oral cancer pathophysiology.
HDHD5 encodes a putative phosphatase belonging to the haloacid dehalogenase superfamily, predicted to require magnesium ion as a cofactor for hydrolyzing phosphate substrates. It is implicated in phosphate metabolic and nucleotide metabolic processes. Disruption of HDHD5 via CRISPR/Cas9 removes its enzymatic activity, potentially disturbing phosphate homeostasis and nucleotide balance within the CAL-27 cells. While direct substrates and downstream effectors remain unknown, the loss of magnesium-dependent dephosphorylation may alter phospho-signaling networks that rely on phosphate turnover. This model thus offers a defined system to explore how a putative metabolic phosphatase contributes to cancer cell physiology.
In the context of OSCC, where proliferating cells demand high phosphate and nucleotide turnover, HDHD5 knockout may reveal critical dependencies on phosphate metabolism for tumor growth and survival. The CAL-27 knockout cells enable researchers to examine whether HDHD5 inactivation influences cell proliferation, colony formation, or migration, thereby linking the phosphatase to oncogenic properties. This model can also be used to investigate how metabolic stress responses differ between HDHD5-proficient and -deficient oral cancer cells.
This HDHD5 knockout model supports diverse research applications, including functional characterization through proliferation, colony formation, and migration assays. Metabolomic profiling and phospho-signaling analyses can elucidate the consequences of HDHD5 deficiency on cellular metabolism. Additionally, the cells are suitable for drug target validation and functional complementation studies. Confirmation of knockout can be conducted via western blotting for HDHD5 protein and RT-qPCR for transcript levels. For technical inquiries and detailed protocols, please contact Ascent Research customer support.
